168 related articles for article (PubMed ID: 18458649)
1. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.
Santolaya ME; Alvarez AM; Aviles CL; Becker A; King A; Mosso C; O'Ryan M; Paya E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2008 Jun; 27(6):538-43. PubMed ID: 18458649
[TBL] [Abstract][Full Text] [Related]
2. Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Venegas M; O'Ryan M; Salgado C; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; de la Maza V; Vergara A; Farfán MJ; Torres JP
Pediatr Infect Dis J; 2013 Dec; 32(12):1318-23. PubMed ID: 24569305
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.
Kitanovski L; Jazbec J; Hojker S; Gubina M; Derganc M
Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):413-5. PubMed ID: 16767494
[No Abstract] [Full Text] [Related]
4. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.
Stryjewski GR; Nylen ES; Bell MJ; Snider RH; Becker KL; Wu A; Lawlor C; Dalton H
Pediatr Crit Care Med; 2005 Mar; 6(2):129-35. PubMed ID: 15730597
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin.
Demirkaya M; Tugcu D; Akcay A; Aydogan G; Akıcı F; Salcioglu Z; Ekmekci H; Sevinir B; Balci Ekmekci O
Pediatr Hematol Oncol; 2015; 32(7):482-9. PubMed ID: 26271020
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
9. An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer.
Haeusler GM; Carlesse F; Phillips RS
Pediatr Infect Dis J; 2013 Oct; 32(10):e390-6. PubMed ID: 23673421
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.
Andreola B; Bressan S; Callegaro S; Liverani A; Plebani M; Da Dalt L
Pediatr Infect Dis J; 2007 Aug; 26(8):672-7. PubMed ID: 17848876
[TBL] [Abstract][Full Text] [Related]
11. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study.
Mian A; Becton D; Saylors R; James L; Tang X; Bhutta A; Prodhan P
Pediatr Blood Cancer; 2012 Aug; 59(2):238-45. PubMed ID: 22535591
[TBL] [Abstract][Full Text] [Related]
14. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.
Santolaya ME; Alvarez AM; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Pilorget J; Salgado C; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
J Clin Oncol; 2001 Jul; 19(14):3415-21. PubMed ID: 11454890
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin to detect invasive bacterial infection in non-toxic-appearing infants with fever without apparent source in the emergency department.
Luaces-Cubells C; Mintegi S; García-García JJ; Astobiza E; Garrido-Romero R; Velasco-Rodríguez J; Benito J
Pediatr Infect Dis J; 2012 Jun; 31(6):645-7. PubMed ID: 22333704
[TBL] [Abstract][Full Text] [Related]
16. Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia--a systemic review and meta-analysis.
Lin SG; Hou TY; Huang DH; He SY; Lin YD; Zhang LY; Hsieh PS
Pediatr Infect Dis J; 2012 Oct; 31(10):e182-8. PubMed ID: 22592515
[TBL] [Abstract][Full Text] [Related]
17. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
18. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
